Rosuvastatin Drug Profile

What is Rosuvastatin?

Rosuvastatin is a prescription medication belonging to a class of drugs called statins, also known as HMG-CoA reductase inhibitors. It is primarily used to lower cholesterol levels and reduce the risk of cardiovascular disease in adults. This medication helps decrease harmful cholesterol while potentially raising beneficial cholesterol levels in the blood.

Uses

Rosuvastatin is approved for several cardiovascular-related conditions:

• High cholesterol (hypercholesterolemia): Reduces elevated levels of total cholesterol, LDL (“bad”) cholesterol, and triglycerides
• Primary prevention of cardiovascular disease: Prevents heart attacks and strokes in adults with multiple risk factors but no existing heart disease
• Secondary prevention: Reduces risk of future cardiovascular events in patients who have already experienced heart attacks, strokes, or other cardiovascular conditions
• Familial hypercholesterolemia: Treats inherited conditions causing extremely high cholesterol levels
• Mixed dyslipidemia: Addresses multiple abnormal lipid levels including elevated triglycerides and low HDL cholesterol

How it works

Rosuvastatin works by blocking an enzyme called HMG-CoA reductase, which plays a crucial role in cholesterol production in the liver. By inhibiting this enzyme, the medication reduces the liver’s ability to manufacture cholesterol, forcing the body to remove existing cholesterol from the bloodstream. This mechanism effectively lowers total cholesterol and LDL cholesterol levels while providing additional benefits for blood vessel health.

Side effects

Common side effects include:

Submit Your Paper

• Headache
• Muscle aches and pain
• Nausea
• Weakness or fatigue
• Stomach pain
• Dizziness
• Constipation
• Memory problems or confusion

Serious side effects requiring immediate medical attention:

• Severe muscle pain, tenderness, or weakness (possible rhabdomyolysis)
• Dark-colored urine or decreased urination
• Yellowing of skin or eyes (jaundice)
• Severe stomach pain
• Unexplained fatigue or fever

Warnings and precautions

• Pregnancy and breastfeeding: Rosuvastatin is contraindicated during pregnancy and breastfeeding due to potential harm to the developing fetus and nursing infant
• Liver disease: Patients with active liver disease or unexplained elevated liver enzymes should not use this medication
• Kidney impairment: Dosage adjustments may be necessary for patients with severe kidney disease
• Muscle disorders: Individuals with a history of muscle problems or those taking certain other medications have increased risk of muscle-related complications
• Alcohol consumption: Excessive alcohol use should be avoided as it may increase the risk of liver problems

Interactions

• Warfarin: May increase bleeding risk by enhancing warfarin’s anticoagulant effects
• Cyclosporine: Significantly increases rosuvastatin levels, requiring dosage adjustments
• Gemfibrozil and fenofibrate: Other lipid-lowering drugs that may increase muscle toxicity risk
• Antacids containing aluminum and magnesium: Can reduce rosuvastatin absorption when taken simultaneously
• Certain HIV protease inhibitors: May increase rosuvastatin concentrations and toxicity risk
• Red yeast rice supplements: Contains natural statins that may increase the risk of muscle problems
• Niacin (high doses): May increase the risk of muscle-related side effects
• Digoxin: Rosuvastatin may increase digoxin levels, requiring monitoring

Check interactions with the GMJ Interaction Checker

Dosage

The typical starting dose for adults ranges from 5 to 20 mg once daily, depending on cholesterol levels and cardiovascular risk factors. The maximum recommended dose is 40 mg daily, though this higher dose is reserved for patients who haven’t achieved target cholesterol levels on lower doses. For patients with severe kidney disease, the maximum dose should not exceed 10 mg daily. Rosuvastatin can be taken with or without food, and the timing of administration does not significantly affect its effectiveness. All dosage decisions should be individualized and determined by a healthcare provider based on patient-specific factors, response to treatment, and tolerability.

Sources: FDA DailyMed drug labels (public domain), BNF, WHO Essential Medicines List. This article is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before starting or stopping any medication.

This work is licensed under Creative Commons Attribution 4.0 International (CC BY 4.0). You are free to share and adapt this content with attribution to GMJ News (news.gmj.ge).